Compare Medtronic PLC (MDT) vs Xcel Energy Inc (XEL) Price & Performance

Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.

The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.

Xcel Energy (XEL) trades at $78.71, down 0.08% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported mixed quarterly earnings, beating Q1 2026 estimates but missing Q3 and Q4 2025. Revenue grew to $14.67 billion in 2025, with a net income margin of 14.14%. Recent news highlights a $60 billion capital plan through 2030 to support electrical demand growth from data centers and industrial expansion.

XEL presents a stable utility investment with a 62.96% analyst buy rating and a consensus price target of $93.86, implying 19% upside. Key opportunities include EPS growth projected at 9.6% annually through 2028, but risks involve regulatory pushback on rate increases and high debt levels with a debt-to-asset ratio of 41.64% in 2025. The stock's valuation at a P/E of 22.7 is reasonable for its growth outlook.